Anti-FGFR1 x Anti-KLB Bispecific Antibody (IgG-IgG) (BSIG-161)

Anti-FGFR1 x Anti-KLB Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-FGFR1 and anti-KLB parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can bind two factors simultaneously and act as mimetic hormone (FGF21) . It is designed for the research of Type 2 diabetes therapy.

Datasheet INQUIRY

Specifications

Targets

FGFR1 & KLB

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Type 2 diabetes

Targets

Target 1

FGFR1

Gene ID

2260

UniProt ID

P11362

Alternative Names

FGFR1; fibroblast growth factor receptor 1; CEK; FLG; HH2; OGD; ECCL; FLT2; KAL2; BFGFR; CD331; FGFBR; FLT-2; HBGFR; N-SAM; FGFR-1; HRTFDS; bFGF-R-1; basic fibroblast growth factor receptor 1; HBGFR; FMS-like tyrosine kinase 2

Target 2

KLB

Gene ID

152831

UniProt ID

Q86Z14

Alternative Names

klotho beta; BKL; KLB; Beta-klotho; B-klotho; BetaKlotho; klotho beta like 3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Anti-FGFR1 x Anti-KLB Bispecific Antibody (IgG-IgG) (BSIG-161). Click the button below to contact us or submit your feedback about this product.

Anti-FGFR1 x Anti-KLB Bispecific Antibody (IgG-IgG) (CAT#: BSIG-161)

Specifications

Targets

Customer Reviews and Q&As